Cmed’s response to the Coronavirus (COVID-19) pandemic

Written by David M Connelly, Chief Executive Officer

Thank you for your continued loyalty and trust in Cmed during these uncertain times. We are continuously monitoring the evolving circumstances surrounding the COVID-19 outbreak and continue operating as normal.

Our highest priority is to maintain the health and safety of our people, customers, partners and suppliers while meeting our service commitments. Cmed has implemented a range of measures in line with World Health Organization guidance to minimise the risks for employees and customers.

Business Continuity procedures have been in place since 10th March 2020 and the Cmed Management Committee meets on a daily basis to monitor the situation. We are actively engaged in managing the implementation of these procedures which include all our staff working remotely across all geographic locations, the deployment of a digital-first strategy and the monitoring of official regulatory guidance.

We continue to update our team members globally with news and information. We also encourage all our employees to be mindful of their health, of others and to support each other.

Despite the recent issues in many countries, we are still able to provide services and technology solutions for all our customers as normal. During these difficult times, encapsia – the game changing EDC and eSource platform – continues to operate with 100% uptime. We are proud to offer industry leading software and features to give our customers the utmost flexibility to allow their studies to continue through all eventualities.

With 20 years of experience as a smart technology-led CRO, Cmed has a strong track record of keeping deliveries on time, to quality and on budget. We believe we are all in this together and will continue to follow our Guiding Principle: We are one team.